MAP2 and melanoma: We showed that a subset of cutaneous primary melanomas exhibits neuronal transdifferentiation and express high molecular weight (mature) microtubule associated protein 2 (MAP2), a marker of neuronal terminal differentiation9, and that MAP2 is a potential prognostic marker10–12.